The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis (vol 44, pg 843, 2022)

被引：0
|
作者：
Cui, Yuying [1 ]
Guo, Yingxue [2 ]
机构：
[1] Jiamusi Univ, Sch Clin Med, Jiamusi 154007, Peoples R China
[2] Jiamusi Univ, Coll Pharm, Jiamusi 154007, Heilongjiang, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2024年 / 46卷 / 02期
关键词：
D O I：
10.1007/s11096-023-01682-x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：555 / 557
页数：3
相关论文
共 50 条
  • [21] Comparative effectiveness and safety of monoclonal antibodies (bevacizumab, cetuximab and panitumumab) in the treatment of metastatic colorectal cancer: Systematic review and metanalysis.
    Silva, Wania Cristina
    Lima, Ellias Magalhaes Abreu
    Araujo, Vania Eloisa
    Santos, Jessica Barreto Ribeiro
    Silva, Michael Ruberson Ribeiro
    Acurcio, Francisco Assis
    Cherchiglia, Mariangela Leal
    Andrade, Eli Iola Gurgel
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] OXALIPLATIN VERSUS IRINOTECAN IN COMBINATION TO CETUXIMAB FOR METASTATIC COLORECTAL CANCER. A SYSTEMATIC REVIEW WITH META-ANALYSIS
    Sasse, Andre Deeke
    Conceicao, Vinicius Correa
    ANNALS OF ONCOLOGY, 2011, 22 : v100 - v100
  • [23] First-line cetuximab versus bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: a systematic review and meta-analysis
    Bobo Zheng
    Xin Wang
    Mingtian Wei
    Quan Wang
    Jiang Li
    Liang Bi
    Xiangbing Deng
    Ziqiang Wang
    BMC Cancer, 19
  • [24] First-line cetuximab versus bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: a systematic review and meta-analysis
    Zheng, Bobo
    Wang, Xin
    Wei, Mingtian
    Wang, Quan
    Li, Jiang
    Bi, Liang
    Deng, Xiangbing
    Wang, Ziqiang
    BMC CANCER, 2019, 19 (1)
  • [25] Efficacy and safety of bevacizumab in elderly or unfit patients with metastatic colorectal cancer: A systematic review and meta-analysis
    Antonuzzo, Lorenzo
    Aprile, Giuseppe
    Barni, Sandro
    Maiello, Evaristo
    Masi, Gianluca
    Petrelli, Fausto
    Scartozzi, Mario
    Torri, Valter
    Pinto, Carmine
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] [A systematic review and meta-analysis on the effectiveness of web-based psychosocial interventions among patients with colorectal cancer] (vol 78, pg 1883, 2022)
    Wan, S. W.
    Chng, Y. J.
    Lim, S. H.
    Chong, C. S.
    Pikkarainen, M.
    He, H. G.
    JOURNAL OF ADVANCED NURSING, 2024, 80 (11) : 4753 - 4754
  • [27] Safety of bevacizumab versus no-bevacizumab treatment used on metastatic colorectal cancer: a systematic review and metanalysis
    Silva, W. C.
    Lima, E. M. E. A.
    Araujo, V. E.
    Santos, J. B. R.
    Silva, M. R. R.
    Cherchiglia, M. L.
    Andrade, E. I. G.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S54 - S55
  • [28] Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer
    Tappenden, P.
    Jones, R.
    Paisley, S.
    Carroll, C.
    HEALTH TECHNOLOGY ASSESSMENT, 2007, 11 (12) : 1 - +
  • [29] A Systematic Review and Meta-Analysis of the Efficacy and Safety of Regorafenib in the Treatment of Metastatic Colorectal Cancer
    Liang, Bingjun
    Tang, Ming
    Huang, Chao
    Yang, Yidian
    He, Yue
    Liao, Shengrong
    Shen, Weizeng
    JOURNAL OF GASTROINTESTINAL CANCER, 2025, 56 (01)
  • [30] Efectiveness of care transition strategies for colorectal cancer patients: a systematic review and meta-analysis (vol 30, pg 6251, 2022)
    Trindade, Leticia Flores
    Boell, Julia Estela Willrich
    Lorenzini, Elisiane
    Montanez, Wilson Canon
    Malkiewiez, Michelle
    Pituskin, Edith
    Kolankiewicz, Adriane Cristina Bernat
    SUPPORTIVE CARE IN CANCER, 2022, 30 (09) : 7819 - 7819
12345